These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14483427)

  • 1. Skin irritation and skin tumor production by beta propiolactone (BPL).
    PALMES ED; ORRIS L; NELSON N
    Am Ind Hyg Assoc J; 1962; 23():257-64. PubMed ID: 14483427
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of beta-propiolactone tumorigenesis in mouse skin by pretreatment with the anti-inflammatory steroid fluocinolone acetonide.
    Woodworth BA; Scribner JD; Scribner NK
    Cancer Lett; 1986 Jun; 31(3):293-7. PubMed ID: 3087615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carcinogenicity of beta-propiolactone and 4-nitroquinoline N-oxide for the skin of the guinea-pig.
    Parish DJ; Searle CE
    Br J Cancer; 1966 Mar; 20(1):200-5. PubMed ID: 5936681
    [No Abstract]   [Full Text] [Related]  

  • 4. The carcinogenicity of beta-propiolactone and 4-nitroquinoline N-oxide for the skin of the golden hamster.
    Parish DJ; Searle CE
    Br J Cancer; 1966 Mar; 20(1):206-9. PubMed ID: 5936682
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of beta-propiolactone-induced neoplasia of the forestomach and large bowel by 4-mercaptobenzene sulfonate in mice and rats.
    Hochalter JB; Wattenberg LW; Coccia JB; Galbraith AR
    Cancer Res; 1988 May; 48(10):2740-3. PubMed ID: 3359434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiments on the carcinogenicity and reactivity of beta-propiolactone.
    SEARLE CE
    Br J Cancer; 1961 Dec; 15(4):804-11. PubMed ID: 13910215
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding of beta-propiolactone to mouse skin DNA in vivo; its correlation with tumor-initiating activity.
    Colburn NH; Boutwell RK
    Cancer Res; 1966 Aug; 26(8):1701-6. PubMed ID: 5923168
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the clastogenic and carcinogenic effects of intravenous beta-propiolactone and benzo(a)pyrene in rats.
    Rees ED; Shuck AE; Lowry JQ; Smith TM; Lipscomb H
    J Environ Pathol Toxicol; 1979; 2(6):1475-85. PubMed ID: 528852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of in vitro transformation by near-u.v. light and its interaction with beta-propiolactone.
    Baturay NZ; Targovnik HS; Reynolds RJ; Kennedy AR
    Carcinogenesis; 1985 Mar; 6(3):465-8. PubMed ID: 3978759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of beta-propiolactone for the sterilization of fermentation media.
    HIMMELFARB P; READ RB; LITSKY W
    Appl Microbiol; 1961 Nov; 9(6):534-7. PubMed ID: 13907502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [INFLUENCE OF BETAPROPIOLACTONE ON THE RESPIRATION OF NORMAL AND NEOPLASTIC TISSUES].
    GANDINI A; MERLI GM
    Pathologica; 1963; 55():273-87. PubMed ID: 14122876
    [No Abstract]   [Full Text] [Related]  

  • 12. Esolation of 3-(2-carboxyethyl)thymine following in vitro reaction of beta-propiolactone with calf thymus DNA.
    Segal A; Solomon JJ; Maté U
    Chem Biol Interact; 1980 Mar; 29(3):335-46. PubMed ID: 6892614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of beta-propiolactone-induced mutagenesis and neoplasia by sodium thiosulfate.
    Wattenberg LW; Hochalter JB; Galbraith AR
    Cancer Res; 1987 Aug; 47(16):4351-4. PubMed ID: 3607767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carcinogenicity of beta-propiolactone for mouseskin.
    GLENDENNING OM; ROE FJ
    Br J Cancer; 1956 Jun; 10(2):357-62. PubMed ID: 13364127
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of propiolactone on rat fibrocytes cultivated in vitro.
    Powell AK
    Br J Cancer; 1966 Jun; 20(2):402-13. PubMed ID: 5944281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action in vitro of beta-propiolactone on transplantable tumors of animals].
    DELLA VOLPE R; GANDINI A; MERLI GM
    Pathologica; 1961; 53():339-47. PubMed ID: 13885193
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationships between the levels of binding to DNA and the carcinogenic potencies in rat nasal mucosa for three alkylating agents.
    Snyder CA; Garte SJ; Sellakumar AR; Albert RE
    Cancer Lett; 1986 Nov; 33(2):175-81. PubMed ID: 3791188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of vacuolating virus (SV 40) by betaprone. II. Evaluation of the oncogenic properties of SV 40 in hamsters after inactivation with betaprone.
    HAYASHI H; LOGRIPPO GA
    Henry Ford Hosp Med Bull; 1963 Mar; 11():93-7. PubMed ID: 13953266
    [No Abstract]   [Full Text] [Related]  

  • 19. A BETA-PROPIOLACTONE STERILIZED MILK FORMULA FOR SPECIFIC PATHOGEN-FREE PIGS.
    AMTOWER WC; CALHOON JR
    Lab Anim Care; 1964 Oct; 14():382-7. PubMed ID: 14212338
    [No Abstract]   [Full Text] [Related]  

  • 20. The binding of beta-propiolactone and some related alkylating agents to DNA, RNA, and protein of mouse skin; relation between tumor-initiating power of alkylating agents and their binding to DNA.
    Colburn NH; Boutwell RK
    Cancer Res; 1968 Apr; 28(4):653-60. PubMed ID: 5649056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.